Spots Global Cancer Trial Database for lung cancer
Every month we try and update this database with for lung cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin | NCT02414269 | Malignant Pleur... Mesothelioma Metastases Lung Cancer Breast Cancer | iCasp9M28z T ce... cyclophosphamid... pembrolizumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
Study of Health Effects of Cosmetic Breast Augmentation | NCT00342953 | Brain Cancer Breast Cancer Lung Cancer Suicide | 21 Years - 69 Years | National Institutes of Health Clinical Center (CC) | ||
Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00667641 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu... | bortezomib paclitaxel | 18 Years - | Rutgers, The State University of New Jersey | |
Breathomics: May it Become an Affordable, New Tool for Early Diagnosis and Screening of Lung Cancer? | NCT06034730 | Lung Cancer | Portable GC dev... | 18 Years - | Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari | |
Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC | NCT03201146 | Lung Cancer Non Small Cell ... Combination Che... Apatinib | Apatinib AP or AC Apatinib 250mg Apatinib 500mg Apatinib 750mg | 18 Years - 70 Years | West China Hospital | |
Reminder Messages for Lung Cancer Screening | NCT05952778 | Skin Flaps Lung Cancer | 40 Years - 80 Years | M.D. Anderson Cancer Center | ||
Behavioral Relaxation Approaches for Insomnia in Lung Cancer Patients | NCT04318249 | Insomnia | Assisted Relaxa... Modified Assist... | 18 Years - 85 Years | Abramson Cancer Center at Penn Medicine | |
Patient Preference Survey for Radiation Oncologists | NCT00595218 | Breast Cancer Prostate Cancer Lung Cancer | Physician behav... Patient Prefere... | 18 Years - | University of Pittsburgh | |
Radiation Therapy Combined With Either Gefitinib or Temozolomide in Pats With NSCLC and Brain Metastases | NCT00238251 | Lung Cancer Metastatic Canc... | gefitinib temozolomide radiation thera... | 18 Years - | Swiss Group for Clinical Cancer Research | |
A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors | NCT04172506 | Solid Tumor Lung Cancer HCC | AK105 | 18 Years - 75 Years | Akeso | |
Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | NCT00002623 | Lung Cancer | carboplatin cisplatin conventional su... radiation thera... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
Pioglitazone for Lung Cancer Chemoprevention | NCT00780234 | Lung Cancer Endobronchial D... | fluorescence br... quantitative hi... PIOGLITAZONE VS... | 18 Years - | VA Office of Research and Development | |
Thoracoscopic Lung Cancer Staging With the Use of Intraoperative Ultrasound | NCT02218242 | Lung Cancer | Intraoperative ... | 18 Years - | University of Kentucky | |
Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer | NCT00892801 | Lung Cancer Metastatic Canc... | RAD001 whole-brain rad... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
A Retrospective Multicenter Review to Evaluate the Performance of the Ion Endoluminal System in Sampling Pulmonary Lesions | NCT05160571 | Lung Cancer Pulmonary Nodul... | Ion Endoluminal... | 18 Years - | Intuitive Surgical | |
S0709: Erlotinib With or Without Carboplatin and Paclitaxel in Stage IIIB or Stage IV Non-Small Cell Lung Cancer | NCT00661193 | Lung Cancer | carboplatin erlotinib hydro... paclitaxel | 18 Years - 120 Years | SWOG Cancer Research Network | |
Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia | NCT00611650 | Lung Cancer Precancerous Co... Tobacco Use Dis... | defined green t... placebo | 45 Years - 74 Years | British Columbia Cancer Agency | |
Feasibility of Magnetic Resonance Spectroscopy in Lung Cancer | NCT02497586 | Lung Cancer | Magnetic resona... | 18 Years - | NHS Greater Glasgow and Clyde | |
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels | NCT04931420 | Metastatic Canc... Foregut Carcino... Gastric Adenoca... Gallbladder Ade... Liver Cancer GI Cancer GI Carcinoma Lung Cancer | Standard of Car... Video-Assisted ... Lobectomy Consolidative R... Ablation Treatm... Resection or Ex... Peritonectomy Transarterial R... | 18 Years - | University of Chicago | |
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) | NCT04198766 | Solid Tumor Non-Small Cell ... Melanoma Head and Neck C... Gastric Cancer Renal Cell Carc... Urothelial Carc... | INBRX-106 - Hex... Pembrolizumab 2... Pembrolizumab 4... | 18 Years - | Inhibrx, Inc. | |
A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer | NCT01591512 | Small Cell Lung... | 18 Years - | Fujirebio Diagnostics, Inc. | ||
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery | NCT00551369 | Lung Cancer | SBRT | 18 Years - | Radiation Therapy Oncology Group | |
Tumor Markers in Lung Cancer | NCT01274468 | Lung Cancer | 45 Years - | University of Oklahoma | ||
Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium | NCT03761901 | Carcinoma, Non-... | 1L treatment 2L Treatment 3L treatment | 18 Years - | AstraZeneca | |
Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens | NCT06252129 | Lung Cancer Lymph Node Meta... Pathologic Proc... | Subjects underg... Control group | 18 Years - | Brigham and Women's Hospital | |
Real World Registry for Use of the Ion Endoluminal System | NCT06004440 | Lung Cancer Multiple Pulmon... Lung Neoplasms Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... | Ion Endoluminal... | 18 Years - | Intuitive Surgical | |
Comparison of Two Techniques of Uniportal VATS Lobectomies for Clinical Stage I Non-Small Cell Lung Cancer | NCT03997799 | Video Assisted ... Non-Small Cell ... | uniportal lobec... | 18 Years - 85 Years | Pulmonary Hospital Zakopane | |
Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer | NCT02379039 | Squamous Carcin... Head and Neck C... Anal Cancer Lung Cancer Esophageal Canc... Cervix Cancer | 18 Years - | Umeå University | ||
A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors | NCT05039931 | Breast Cancer Solid Tumor | GNC-035 | 18 Years - | Sichuan Baili Pharmaceutical Co., Ltd. | |
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors | NCT00471432 | Bladder Cancer Breast Cancer Kidney Cancer Lung Cancer Ovarian Cancer Prostate Cancer Unspecified Adu... | custirsen sodiu... docetaxel pharmacological... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
Use of Dual Energy Computed Tomography in Thoracic Radiotherapy Planning. | NCT04863027 | Lung Cancer Lung Function D... Radiation Pneum... | Thoracic radiot... | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
ALK Rearrangements in Lung Adenocarcinoma: Epidemiology in Latin America (CLICaP) | NCT02502240 | Lung Cancer | 18 Years - 90 Years | Instituto Nacional de Cancerologia de Mexico | ||
Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors | NCT00006036 | Head and Neck C... Lung Cancer Ovarian Cancer Unspecified Adu... | cisplatin lurtotecan lipo... | 18 Years - 120 Years | Canadian Cancer Trials Group | |
Early Detection of Lung Cancer With Low-dose Multislice Computed Tomography | NCT02754388 | Lung Cancer | 20 Years - | National Taiwan University Hospital | ||
UNITO-001- Study in HRR/PDL1 Positive MPM/NSCLC | NCT04940637 | Lung Cancer Mesothelioma | niraparib and d... | 18 Years - | University of Turin, Italy | |
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) | NCT00600496 | Breast Cancer Breast Neoplasm... Colon Cancer Colonic Cancer Colon Neoplasms Lung Cancer Melanoma Kidney Cancer | AZD6244 Dacarbazine Erlotinib Docetaxel Temsirolimus | 18 Years - 130 Years | AstraZeneca | |
Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer | NCT00003364 | Lung Cancer | cisplatin cyclophosphamid... doxorubicin hyd... etoposide vincristine sul... radiation thera... | - 74 Years | National Cancer Institute (NCI) | |
Preoperative Percutaneous Radiofrequency Ablation of Primary and Secondary Lung Tumors | NCT00610844 | Lung Cancer Lung Metastasis | pulmonary radio... | 18 Years - | University Hospital Tuebingen | |
Italian Lung Cancer Screening Trial (ITALUNG) | NCT02777996 | Lung Cancer | Low Dose Comput... | 55 Years - 69 Years | Cancer Prevention and Research Institute, Italy | |
Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study | NCT04783168 | Lung Carcinoma | Best Practice Health Promotio... Medical Device ... Quality-of-Life... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
Genetically-informed Therapies for Patients With Metastatic Cancer | NCT02000739 | Metastatic Canc... | Genetically Inf... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC | NCT00410189 | Lung Cancer | ZD6474 | 18 Years - | M.D. Anderson Cancer Center | |
Pulmonary Rehabilitation After Minimal Invasive Surgery in Lung Cancer | NCT05136300 | Lung Cancer Surgery | Pulmonary rehab... | 18 Years - 80 Years | Isala | |
Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer | NCT00654030 | Non-Small Cell ... | 1650-G Vaccine | 18 Years - | University of Kentucky | |
Pleural Catheters Versus Thoracoscopic Pleurodesis | NCT01117740 | Lung Cancer | MDASI Questionn... | 18 Years - | M.D. Anderson Cancer Center | |
Combination Chemotherapy in Treating Patients With Stage I, II, or IIIA Non-small Cell Lung Cancer That Has Been Surgically Removed | NCT00003053 | Lung Cancer | cisplatin etoposide adjuvant therap... | - 70 Years | National Cancer Institute (NCI) | |
Lung Ultrasound in Pleuritic Chest Pain | NCT02107001 | Community Acqui... Pleuritis Pulmonary Embol... Lung Cancer | Lung ultrasound | 18 Years - | University of Milan | |
Can a Pulmonologist Reliably Assess the Tumor Burden on ROSE Slides Obtained From Pulmonary Nodules and Lymphadenopathy | NCT03845764 | Lung Cancer | Rapid on-site e... | 18 Years - | Maggiore Bellaria Hospital, Bologna | |
Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC | NCT00378404 | Non-Small Cell ... | Docetaxel Radiation | 18 Years - | University of Kentucky | |
EUS-B-FNA vs EUS-FNA for Left Adrenal Gland Analysis in Lung Cancer Patients | NCT02538380 | Suspected Left ... | EUS-B-FNA follo... | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer | NCT00062335 | Lung Cancer | radiation thera... | - | European Organisation for Research and Treatment of Cancer - EORTC | |
Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | NCT00310115 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | Smoking Prevent... Counseling Inte... Counseling Inte... | 18 Years - | M.D. Anderson Cancer Center | |
Support for Cancer Patients Awaiting News | NCT06199570 | Lung Cancer | Adapted Stress ... Enhanced Usual ... | 18 Years - | Hackensack Meridian Health | |
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery | NCT00553462 | Lung Cancer | carboplatin erlotinib hydro... paclitaxel albu... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Construction and Effect Evaluation of the Low Load Blood Flow Restriction Training Program for Lung Cancer Patients Complicated With Sarcopenia During Chemotherapy | NCT06347965 | Sarcopenia Lung Neoplasms | Low load blood ... Progressive res... | 18 Years - | Zhejiang University | |
Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study | NCT05873790 | Lung Cancer | Serplulimab plu... | 18 Years - 75 Years | The First Hospital of Jilin University | |
Genetically-informed Therapies for Patients With Metastatic Cancer | NCT02000739 | Metastatic Canc... | Genetically Inf... | 18 Years - | Dartmouth-Hitchcock Medical Center | |
One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy | NCT00358397 | Tumors | Clostridium nov... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Bronchial Washing Beforeand After Endobronchial Biopsy and Bronchial Brushing | NCT05569629 | Lung Cancer | Bronchial washi... | 18 Years - | Chinese University of Hong Kong | |
Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction | NCT00009789 | Lung Cancer | accelerated con... | 18 Years - | Alliance for Clinical Trials in Oncology | |
Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC) | NCT01069328 | Carcinoma, Non-... Lung Cancer | Nexavar (Sorafe... Nexavar (Sorafe... Bevacizumab Bevacizumab Bevacizumab Bevacizumab Paclitaxel Carboplatin | 18 Years - | Bayer | |
Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer | NCT00005032 | Lung Cancer | oblimersen sodi... paclitaxel | 18 Years - | University of Chicago | |
Mass Spectral Fingerprinting in Lung Cancer | NCT02781857 | Lung Cancer | No intervention | 18 Years - 85 Years | University of Zurich | |
Examination Of Exercise Adherence İn Lung Cancer Patients Given Calisthenic Exercise | NCT05332171 | Exercise Addict... Lung Cancer | Pyhsiohterapy a... | 18 Years - 65 Years | Hasan Kalyoncu University | |
A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors | NCT01176500 | Colon Cancer Lung Cancer Cervical Cancer Renal Cell Carc... Uterine Cancer | (18)Fluciclatid... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC) | NCT01562028 | Lung Cancer | Erlotinib Bevacizumab | 18 Years - | ETOP IBCSG Partners Foundation | |
Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) | NCT00373204 | Lung Cancer | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
Microbiota Transplant in Advanced Lung Cancer Treated With Immunotherapy | NCT04924374 | Lung Cancer | Microbiota Tran... anti PD1 therap... | 18 Years - | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | |
Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer | NCT00897533 | Lung Cancer | gene mapping polymorphism an... diagnostic labo... immunohistochem... | - 120 Years | Eastern Cooperative Oncology Group | |
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers | NCT00568490 | Head and Neck C... Lung Cancer Lip Cancer Lip Neoplasms Head and Neck C... | Tumor biopsy Phlebotomy | 18 Years - | Stanford University | |
On Dose Efficiency of Modern CT-scanners in Chest Scans | NCT04996693 | Pneumonia Lung Cancer Pulmonary Embol... Pulmonary Disea... Aortic Stenosis | Imaging on Scan... CT Scan using a... CT Scan using a... | 18 Years - | University Hospital Augsburg | |
GPC3/Mesothelin-CAR-γδT Cells Against Cancers | NCT06196294 | Pancreas Cancer Lung Cancer Liver Cancer Mesothelioma CAR-T Cell Ther... Solid Tumor, Ad... | Cell therapy fo... | 18 Years - 75 Years | Second Affiliated Hospital of Guangzhou Medical University | |
Biomarker Discovery and Validation in Lung Cancer | NCT01147562 | Lung Cancer | Collection of b... | 18 Years - | Public Research Centre Health, Luxembourg | |
DNP-Modified Autologous Tumor Cell Vaccine for Resectable Non-Small Cell Lung Cancer | NCT00298298 | Non-Small Cell ... | L-Vax: Autologo... | - | AVAX Technologies | |
Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort | NCT02687997 | Sleep Apnea Hyp... COPD Emphysema Lung Cancer | poligraphy | 55 Years - 75 Years | Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | |
The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients | NCT00859768 | Breast Cancer Lung Cancer Prostate Cancer Bladder Cancer Cervix Cancer Cancer of Endom... Cancer of Skin Non-Hodgkin Lym... Colorectal Canc... | Questionnaire a... | 18 Years - | Netherlands Open University | |
Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer | NCT03505515 | Lung Cancer Non-small Cell ... Small Cell Lung... | 18 Years - | Bristol-Myers Squibb | ||
Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum | NCT00573885 | Lung Cancer Tobacco Use Dis... | defined green t... placebo | 45 Years - 74 Years | British Columbia Cancer Agency | |
Generation Of a Lung Biobank for Future Use | NCT05234138 | Cancer Lung Cancer | Blood Sample | 18 Years - | Royal Marsden NHS Foundation Trust | |
Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma | NCT00192829 | Non-Small Cell ... Venous Thromboe... | Blood sample wi... | - | Rambam Health Care Campus |